Back to top
more

ColgatePalmolive (CL)

(Delayed Data from NYSE)

$92.57 USD

92.57
4,568,041

+1.80 (1.98%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $92.61 +0.04 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (42 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Colgate-Palmolive (CL) Q3 Earnings Beat Estimates

by Zacks Equity Research

Colgate-Palmolive (CL) delivered earnings and revenue surprises of 1.43% and -0.74%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Things You Need to Know Before Colgate's (CL) Q3 Earnings

by Zacks Equity Research

Higher raw material and SG&A costs, and adverse currency are likely to get reflected in Colgate's (CL) third-quarter margins and earnings. However, pricing gains and innovation might have offset woes.

Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ecolab's (ECL) Gallay Medical Buyout to Boost Healthcare Arm

by Zacks Equity Research

The addition of Gallay Medical is likely to boost Ecolab's (ECL) Healthcare offerings.

Colgate's (CL) Growth Efforts on Track, Cost Woes Persist

by Zacks Equity Research

Colgate (CL) is grappling with weak margin trend and adverse impacts of currency. Nevertheless, its accelerated investments in brands, higher pricing and strong innovations bode well for growth.

Has Colgate-Palmolive (CL) Outpaced Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Is (CL) Outperforming Other Consumer Staples Stocks This Year?

Here's Why Procter & Gamble Stock is Worth Betting on Now

by Zacks Equity Research

Procter & Gamble's (PG) focus on improving its product portfolio through strategic initiatives bodes well. Also, the company is on track with its cost-saving plans.

Clorox (CLX) Declines Post Soft FY20 View: Is This Temporary?

by Zacks Equity Research

Headwinds in the Charcoal, and Bags and Wraps businesses are hurting Clorox's (CLX) sales performance. But its robust fundamentals, initiatives and earnings trend indicate solid long-term prospects.

Colgate (CL) Displays a Solid Run-Up of More Than 20% YTD

by Zacks Equity Research

Colgate (CL) is benefiting from higher pricing, strong innovation and expansion efforts. Moreover, the company's savings programs are delivering impressive result.

Colgate-Palmolive (CL) Up 0.4% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why Procter & Gamble is a Hot Investment Pick Now

by Zacks Equity Research

Procter & Gamble (PG) is benefiting from ongoing initiatives to improve productivity. Also, the company is focused on product improvement, packaging and marketing initiatives and cost-saving plans.

Church & Dwight Likely to Keep Gaining on Solid Sales Trend

by Zacks Equity Research

Church & Dwight's (CHD) sales are gaining from continued category growth and healthy market share gains. The company's consumer international business has long been contributing to the top line.

Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock

by Zacks Equity Research

Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.

Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat

by Zacks Equity Research

Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.

Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y

by Zacks Equity Research

Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.

Colgate-Palmolive (CL) Lags Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Colgate-Palmolive (CL) delivered earnings and revenue surprises of -1.37% and -0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Why Colgate-Palmolive (CL) Might Surprise This Earnings Season

by Zacks Equity Research

Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Nalak Das headshot

Buy 5 High-Flying Stocks Ahead of Q2 Earnings This Week

by Nalak Das

It will be prudent to invest in stocks that are likely to beat earnings estimates in the second quarter this week.

Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Things You Need to Know Before FEMSA's (FMX) Q2 Earnings

by Zacks Equity Research

FEMSA's (FMX) second-quarter 2019 results are likely to be impacted by ongoing cost headwinds, which should continue to hurt margins. However, its growth efforts might provide some respite.

Check Out Colgate's (CL) Probability to Beat in Q2 Earnings

by Zacks Equity Research

Colgate's (CL) growth efforts indicate that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.

Can Colgate-Palmolive (CL) Keep the Earnings Surprise Streak Alive?

by Zacks Equity Research

Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Colgate (CL) to Expand Skin Care Range With Filorga Buyout

by Zacks Equity Research

Colgate (CL) to expand the personal care portfolio with the acquisition of skin care business of France-based Filorga.

Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins

by Zacks Equity Research

Colgate's (CL) strong surprise trend, higher pricing, strong innovation and expansion efforts bode well. However, high input costs and currency headwinds concerns.

Rajani Lohia headshot

Soap & Cleaning Materials Industry Outlook Upbeat on New Products

by Rajani Lohia

The FMCG space is likely to gain from investment in brands, innovation, cost-containment and pricing actions. However, its struggles against higher raw material and transportation costs continue.